Theraphage
Company

Last deal

Amount

Pre-Seed

Stage

12.03.2020

Date

1

all rounds

General

About Company
Theraphage develops bacteriophage-based immunotherapeutics for global use.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2018

Number of employees

Company Type

For Profit

Last funding type

Pre-Seed

IPO status

Private

Description

The company's mission is to create specialized, safe, and effective treatments for infectious diseases using natural biologics. They strive to make cancer a thing of the past by producing affordable and accessible immunotherapeutics. Theraphage is committed to improving global health by developing innovative solutions to combat infectious diseases.
Contacts